Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine
NCT00856752
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetics
Interventions
DRUG:
NRL972
DRUG:
NRL972
DRUG:
NRL972
Sponsor
Norgine